Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ensysce Biosciences (ENSC) Income from Non-Controlling Interests (2020 - 2025)

Ensysce Biosciences (ENSC) has disclosed Income from Non-Controlling Interests for 5 consecutive years, with -$74.0 as the latest value for Q1 2024.

  • On a quarterly basis, Income from Non-Controlling Interests rose 98.12% to -$74.0 in Q1 2024 year-over-year; TTM through Dec 2024 was -$74.0, a 99.44% increase, with the full-year FY2024 number at -$74.0, up 99.44% from a year prior.
  • Income from Non-Controlling Interests was -$74.0 for Q1 2024 at Ensysce Biosciences, up from -$965.0 in the prior quarter.
  • In the past five years, Income from Non-Controlling Interests ranged from a high of $12226.0 in Q4 2022 to a low of -$35948.0 in Q3 2021.
  • A 5-year average of -$8856.5 and a median of -$3941.0 in 2023 define the central range for Income from Non-Controlling Interests.
  • Peak YoY movement for Income from Non-Controlling Interests: skyrocketed 5813.08% in 2022, then crashed 2265.38% in 2023.
  • Ensysce Biosciences' Income from Non-Controlling Interests stood at -$20014.0 in 2020, then skyrocketed by 98.93% to -$214.0 in 2021, then surged by 5813.08% to $12226.0 in 2022, then plummeted by 107.89% to -$965.0 in 2023, then soared by 92.33% to -$74.0 in 2024.
  • Per Business Quant, the three most recent readings for ENSC's Income from Non-Controlling Interests are -$74.0 (Q1 2024), -$965.0 (Q4 2023), and -$1235.0 (Q3 2023).